Abecomotide (CAS 907596-50-3) | Immunological Peptide for Active Immunization Research

Description Contents hide 1 Product Description 2 Product Specifications 3 Mechanism of Action & Research Applications 3.1 Mechanism of Action 3.2 Research Applications 4 Side Effects (Observed in Research Models) 5 Disclaimer 6 Keywords Product DescriptionAbecomotide is a synthetic biologically active peptide (CAS 907596-50-3) investigated as a potential immunological agent for active immunization. Unlike conventional vaccine components derived from attenuated pathogens or recombinant proteins, Abecomotide is designed to function as a defined peptide immunogen, targeting specific immune mechanisms with enhanced safety, reproducibility, and precision.The immunological principle behind Abecomotide is based on the ability of short peptide epitopes to mimic critical regions of antigens, thereby stimulating a controlled adaptive immune response. This allows researchers to evaluate peptide-based strategies for vaccine development, immune system modulation, and antigen-specific tolerance or immunity.Compared to traditional vaccines, which often include whole organisms or large protein complexes, peptide immunogens like Abecomotide offer several advantages for research:High specificity – allows researchers to dissect responses to individual epitopes.Controlled immunogenicity – enables modulation of immune activation strength and quality.Reduced off-target risks – avoids unnecessary activation of unrelated immune pathways.Consistency – fully synthetic peptides guarantee reproducible composition.Customizable design – sequences can be altered to test immunological hypotheses.These properties make Abecomotide a versatile laboratory tool for research in vaccine immunology, infectious disease models, tumor immunology, and autoimmune modulation.In multiple studies, Abecomotide has been explored as an active immunization agent, capable of engaging both B-cell and T-cell responses. By presenting epitopes recognized by antigen-specific receptors, it can stimulate antibody production and T-cell proliferation, leading to measurable adaptive immunity in experimental models. This makes it particularly relevant in the context of:Experimental vaccine prototypesEpitope mapping in immunology researchModeling immune response regulationComparative studies of peptide vs. protein immunogensImportantly, Abecomotide is not a therapeutic or commercial vaccine product. Instead, it is supplied exclusively for laboratory-based immunological studies, where it enables researchers to explore fundamental immune mechanisms, peptide vaccine design, and immunomodulatory approaches.Product SpecificationsParameterDetailsProduct NameAbecomotideCAS Number907596-50-3Molecular TypeSynthetic biologically active peptideFunctional RoleImmunological agent (active immunization research)AppearanceWhite to off-white lyophilized powderPurity? 98% (HPLC verified)Molecular FormulaAvailable upon requestSolubilitySoluble in water, PBS, and DMSOStabilityStable for ? 24 months in lyophilized formStorage Conditions-20°C, dry, light-protectedMechanismInduces adaptive immune response by peptide epitope recognitionApplicationsVaccine research, immunology studies, immune modulationExperimental ModelsIn vitro lymphocyte assays, in vivo immunization studiesGMP ComplianceManufactured under GMP conditionsSafety NoteFor research use only; not for therapeutic or diagnostic useThe high purity and GMP-compliant production process ensure reproducible experimental outcomes and reliability across immunological assays and comparative studies.Mechanism of Action & Research ApplicationsMechanism of ActionEpitope-Specific RecognitionAbecomotide presents defined peptide epitopes that are processed and displayed on MHC class I or II molecules, triggering recognition by antigen-specific T-cell receptors.B-cell ActivationBy mimicking antigen structures, it can induce antibody generation in experimental immunization studies.Adaptive Immune Memory FormationRepeated exposure allows for evaluation of immunological memory responses, essential for vaccine design.Immunological ModulationDepending on sequence design, Abecomotide can induce tolerance, partial activation, or full adaptive responses, making it a flexible immunological probe.Research ApplicationsPeptide Vaccine ResearchAbecomotide is a prototype molecule for investigating synthetic epitope vaccines.Immunological MechanismsProvides a clean system to evaluate T-cell and B-cell activation without the complexity of whole-pathogen immunogens.Autoimmune ModulationUseful in studying how defined peptides may alter self-reactive immune responses.Cancer ImmunologyModel for testing whether peptide epitopes can trigger anti-tumor T-cell responses.Adjuvant StudiesAllows researchers to evaluate the role of different immune adjuvants in enhancing peptide immunogenicity.Comparative StudiesServes as a reference in studies comparing protein-based vs. peptide-based immunization.By serving as a simplified and customizable model, Abecomotide helps immunologists dissect the building blocks of adaptive immunity and design next-generation strategies for vaccination, immune tolerance, and immune engineering.Side Effects (Observed in Research Models)In preclinical and laboratory research models, Abecomotide has demonstrated certain effects that researchers should note:Immune OveractivationIn some studies, high doses may induce hyperactive immune responses, leading to exaggerated cytokine production.Peptide-Specific ToleranceRepeated exposure may also lead to T-cell anergy or tolerance, which could complicate interpretation.Allergic SensitizationAs a peptide, Abecomotide may occasionally induce hypersensitivity or antibody formation against the synthetic epitope.Dose-Dependent OutcomesLow and high concentrations can yield very different immunological effects, making careful titration essential.Model LimitationsResults observed in murine or in vitro models may not translate directly to human immunology, and findings must be interpreted within that limitation.?? These side effects are context-specific to laboratory models and do not imply suitability for therapeutic use. Abecomotide is strictly a research-use peptide.DisclaimerFor laboratory research use only. Not for human or veterinary use. We do not sell to patients.KeywordsAbecomotide CAS 907596-50-3Biologically active peptide immunogenActive immunization peptide researchSynthetic peptide vaccine modelImmunological research peptideAntigen-specific immune modulation peptideGMP-grade peptide immunogenLaboratory immunization peptideAdaptive immunity peptidePeptide vaccine prototype